As of Apr 20
| -0.40 / -0.80%|
The 19 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 47.00, with a high estimate of 58.00 and a low estimate of 40.00. The median estimate represents a -5.34% decrease from the last price of 49.65.
The current consensus among 23 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.